Amnestic MCI Patients’ Perspectives toward Disclosure of Amyloid PET Results in a Research Context

被引:0
|
作者
Gwendolien Vanderschaeghe
Jolien Schaeverbeke
Rik Vandenberghe
Kris Dierickx
机构
[1] KU Leuven,Centre for Biomedical Ethics and Law, Department of Public Health and Primary Care
[2] KU Leuven,Laboratory for Cognitive Neurology, Department of Neurosciences
[3] Alzheimer Research Centre KU Leuven,Memory Clinic / Neurology
[4] Leuven research Institute for Neurodegenerative Disorders,undefined
[5] University Hospitals Leuven (UZ Leuven,undefined
[6] Campus Gasthuisberg),undefined
来源
Neuroethics | 2017年 / 10卷
关键词
Ethics; Amnestic MCI; Clinical trial; Qualitative research; Disclosure of return of results; Individual research results; Biomarker; Amyloid PET; Belgium;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:281 / 297
页数:16
相关论文
共 50 条
  • [1] Amnestic MCI Patients' Perspectives toward Disclosure of Amyloid PET Results in a Research Context
    Vanderschaeghe, Gwendolien
    Schaeverbeke, Jolien
    Vandenberghe, Rik
    Dierickx, Kris
    NEUROETHICS, 2017, 10 (02) : 281 - 297
  • [2] Amnestic MCI patients’ experiences after disclosure of their amyloid PET result in a research context
    Gwendolien Vanderschaeghe
    Jolien Schaeverbeke
    Rose Bruffaerts
    Rik Vandenberghe
    Kris Dierickx
    Alzheimer's Research & Therapy, 9
  • [3] Amnestic MCI patients' experiences after disclosure of their amyloid PET result in a research context
    Vanderschaeghe, Gwendolien
    Schaeverbeke, Jolien
    Bruffaerts, Rose
    Vandenberghe, Rik
    Dierickx, Kris
    ALZHEIMERS RESEARCH & THERAPY, 2017, 9
  • [4] Longitudinal Changes of Amyloid Burdens in Subcortical Vascular MCI Patients: Comparison with Amnestic MCI Patients
    Kim, Hee Jin
    Na, Duk L.
    Seo, Sang Won
    ANNALS OF NEUROLOGY, 2014, 76 : S93 - S93
  • [5] LTP-like plasticity is impaired in amyloid-positive amnestic MCI but independent of PET-amyloid burden
    Buss, Stephanie S.
    Press, Daniel Z.
    McDonald, Katherine
    Kitchener, Erin
    O'Connor, Margaret
    Donohoe, Kevin
    Shafi, Mouhsin M.
    Pascual-Leone, Alvaro
    Fried, Peter J.
    NEUROBIOLOGY OF AGING, 2020, 96 : 109 - 116
  • [6] Amyloid PET in MCI Patients with Subsyndromal Depressive Symptoms
    Brendel, Matthias
    Sauerbeck, Julia
    Delker, Andreas
    Pogarell, Oliver
    Bartenstein, Peter
    Rominger, Axel
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [7] Disclosure of amyloid PET scan results: A systematic review
    Kim, Hyejin
    Lingler, Jennifer H.
    BRAIN IMAGING, 2019, 165 : 401 - 414
  • [8] Added value of amyloid PET in individualized risk predictions for MCI patients
    van Maurik, Ingrid S.
    van der Kall, Laura M.
    de Wilde, Arno
    Bouwman, Femke H.
    Scheltens, Philip
    van Berckel, Bart N. M.
    Berkhof, Johannes
    van der Flier, Wiesje M.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2019, 11 (01) : 529 - 537
  • [9] Safety of Disclosing Amyloid Imaging Results to MCI and AD Patients
    Taswell, Carl
    Donohue, Cheryl L.
    Mastwyk, Maree
    Louey, Andrea
    Giummarra, Jacqueline
    Darby, David
    Villemagne, Victor
    Masters, Colin
    Rowe, Christopher
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 25 (03): : S129 - S129
  • [10] Cognitively unimpaired adults' reactions to disclosure of amyloid PET scan results
    Largent, Emily A.
    Harkins, Kristin
    van Dyck, Christopher H.
    Hachey, Sara
    Sankar, Pamela
    Karlawish, Jason
    PLOS ONE, 2020, 15 (02):